We are happy for the opportunity to feature so many incredible companies over the past years and witness their successes.
Toby Health uses noninvasive urine spectroscopy and AI to detect diseases, inspired by animal detection abilities. Their goal is to make diagnostics more accurate, accessible, and affordable.
The Future of Cell and Gene Therapy is Automated
Limula offers a modular solution for on-demand and at-scale manufacturing of cell therapies in a single device.
Better blood collection for the future of healthcare.
“With the Cinna™, we are closing the gap in at-home testing”
Esya utilizes patented intracellular analytics utilizing DNA nanoprobes and AI to diagnose Alzheimer’s Disease before symptoms are exhibited.
Toku Eyes has created a multi-modal AI platform that uses retinal images to provide instant healthcare diagnostics, personalized prognostics, and general health risk assessments, screening for preventable blindness and cardiovascular disease risk.
Meet our first ever 42PLUS1 winner – Alertgy
Alertgy, presented by the CEO Marc Rippen, has developed a 100% non-invasive, real-time, real blood glucometer that lasts a long time. As a cutting-edge biotech company, they’re working to revolutionize the way diabetics and pre-diabetics manage their diabetes.